Sitafloxacin Hydrate 5mg | ≥99%
CSNpharm
Sitafloxacin Hydrate is a fluoroquinolone antibiotic with promising effect on the treatment of Buruli ulcer.
More Information Supplier PageSitafloxacin Hydrate
Search Results
Sitafloxacin Hydrate 1mg | ≥99%
CSNpharm
Sitafloxacin Hydrate is a fluoroquinolone antibiotic with promising effect on the treatment of Buruli ulcer.
More Information Supplier PageSitafloxacin Hydrate
SA4503 25mg | ≥98%
CSNpharm
SA4503 is an agonist of opioid sigma1 receptor (σ1R) with IC50 of 17.4 nM.
More Information Supplier PageSA4503
SA4503 50mg | ≥98%
CSNpharm
SA4503 is an agonist of opioid sigma1 receptor (σ1R) with IC50 of 17.4 nM.
More Information Supplier PageSA4503
SA4503 10mg | ≥98%
CSNpharm
SA4503 is an agonist of opioid sigma1 receptor (σ1R) with IC50 of 17.4 nM.
More Information Supplier PageSA4503
AZD3264 50mg | ≥99%
CSNpharm
AZD3264 is an IkB-kinase IKK2 Inhibitor. IKK2 has been identified as one of the pathways to treat inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.
More Information Supplier PageAZD3264
AZD3264 10mg | ≥99%
CSNpharm
AZD3264 is an IkB-kinase IKK2 Inhibitor. IKK2 has been identified as one of the pathways to treat inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.
More Information Supplier PageAZD3264
AZD3264 25mg | ≥99%
CSNpharm
AZD3264 is an IkB-kinase IKK2 Inhibitor. IKK2 has been identified as one of the pathways to treat inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.
More Information Supplier PageAZD3264
AZD3264 5mg | ≥99%
CSNpharm
AZD3264 is an IkB-kinase IKK2 Inhibitor. IKK2 has been identified as one of the pathways to treat inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.
More Information Supplier PageAZD3264
AZD3264 2mg | ≥99%
CSNpharm
AZD3264 is an IkB-kinase IKK2 Inhibitor. IKK2 has been identified as one of the pathways to treat inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.
More Information Supplier PageAZD3264